跳至主要内容
临床试验/NCT03800641
NCT03800641已完成4 期

A Study of Dexmedetomidine Pharmacokinetics for Preoperative Sedation With Administration of Oral, Intravenous and Nasal Drops

Eye & ENT Hospital of Fudan University1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2019年1月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
45
试验地点
1
主要终点
Dexmedetomidine pharmacokinetic curve

研究概览

简要总结

Proper preoperative sedation can reduce patients' anxiety, enhance patients' cooperation and reduce perioperative complications. The investigators would explore the sedative effects of dexmedetomidine (DEX) with the administration of oral, intravenous and nasal drops, and detect DEX blood concentration in 15 participants, respectively. Pharmacokinetic parameters are detected at 8 time points ( before DEX administration, 10 min, 20 min, 30 min, 45 min, 60min, 90min and 120 min after administration). 3 ml arterial blood was collected at each time point. The blood samples are detected by mass spectrometer. The aim of this study is to investigate appropriate administration time and route for DEX sedation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 45 participants who undergo tympanoplasty would be enrolled after signment the informed consent.

排除标准

  • The participants were excluded with any diseases about respiration, circulation, liver and kidney.

研究组 & 干预措施

oral administration

Experimental

oral administration of dexmedetomidine 4μg/kg

干预措施: Dexmedetomidine (Drug)

intravenous administration

Active Comparator

intravenous administration of dexmedetomidine 0.8μg/kg

干预措施: Dexmedetomidine (Drug)

nasal administration

Experimental

nasal administration of dexmedetomidine 1μg/kg

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Dexmedetomidine pharmacokinetic curve

时间窗: 120 min DEX pharmacokinetics

Dexmedetomidine (DEX) blood concentration are detected at 8 time points (before DEX administration, 10 min, 20 min, 30 min, 45 min, 60min, 90min and 120 min after administration) in the groups of oral, intravenous and nasal drops administration of DEX. 3 ml arterial blood was collected at each time point. The blood samples are detected by mass spectrometer to detect blood concentration of DEX. Then DEX pharmacokinetic curve is made according to the DEX blood concentration.

次要结局

  • Effect of sedation(10min after administration)
  • Evaluation of surgical field(30min after administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jinhong Wu

Principal Investigator

Eye & ENT Hospital of Fudan University

研究点 (1)

Loading locations...

相似试验